Sugammadex 4.0 mg kg-1 reversal of deep rocuronium-induced neuromuscular blockade: A multicenter study in Chinese and Caucasian patients

Journal of Anesthesia and Clinical Research

Volumn 5, Issue 5, 2014, Pages

  Yu, Buwei ^a   Wang, Xiangrui ^b   Helbo Hansen, Hans S ^c   Huang, Wen Qi ^d   Askeland, Bjarte ^e   Li, Shitong ^f   Ding, Zhengnian ^g   Abels, Esther ^h   Rietbergen, Henk ^h   Woo, Tiffany ⁱ   Pendeville, Philippe ^j  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^g THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^h MSD   (Netherlands)

ⁱ MERCK RESEARCH LABORATORIES   (United States)

^j CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

more..

Author keywords

Asian; Caucasian; Chinese; Efficacy; Neuromuscular blockade; Rocuronium; Safety; Sugammadex

Indexed keywords

EID: 84903280961     PISSN: None     EISSN: 21556148     Source Type: Journal    
DOI: 10.4172/2155-6148.1000408     Document Type: Article

References (26)

1. Danic MJ, Chow M, Alexander G, Bhandari A, Menon M, et al. (2007) Anesthesia considerations for robotic-assisted laparoscopic prostatectomy: a review of 1,500 cases. J Robotic Surg 1: 119-123.
2. Amaki Y, Haziri H, Sugimoto N, Shudo Y, Kobayashi K (1990) The degree of muscle relaxation requested by the surgens during upper abdominal surgery. J Anesth 4: 249-252.
3. Ogunnaike BO, Jones SB, Jones DB, Provost D, Whitten CW (2002) Anesthetic considerations for bariatric surgery. AnesthAnalg 95: 1793-1805.
4. Geldner G, Niskanen M, Laurila P, Mizikov V, Hübler M, et al. (2012) A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery. Anaesthesia 67: 991-998.
5. Jones RK, Caldwell JE, Brull SJ, Soto RG (2008) Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 109: 816-824.
6. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS, et al. (1996) Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade. Can J Anaesth 43: 932-938.
7. Lien CA (2011) Development and potential clinical impairment of ultra-short-acting neuromuscular blocking agents. Br J Anaesth 107 Suppl 1: i60-71.
8. Caldwell JE (1995) Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. AnesthAnalg 80: 1168-1174.
9. Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, et al. (2010) Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevofurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 27: 874-881.
10. Collins LM, Bevan JC, Bevan DR, Villar GC, Kahwaji R, et al. (2000) The prolonged duration of rocuronium in Chinese patients. AnesthAnalg 91: 1526-1530.
11. Dahaba AA, Perelman SI, Moskowitz DM, Bennett HL, Shander A, et al. (2006) Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage. Anesthesiology 104:950-953.
12. Fiset P, Donati F, Balendran P, Meistelman C, Lira E, et al. (1991) Vecuronium is more potent in Montreal than in Paris. Can J Anaesth 38: 717-721.
13. Katz RL, Norman J, Seed RF, Conrad L (1969) A comparison of the effects of suxamethonium and tubocurarine in patients in London and New York. Br J Anaesth 41: 1041-1047.
14. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, et al. (2007) Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. ActaAnaesthesiolScand 51: 789-808.
15. International Conference on Harmonisation. Guidance for Industry, E6 Good Clinical Practice: Consolidated Guidance.
16. Claudius C, Viby-Mogensen J (2008) Acceleromyography for use in scientifc and clinical practice: a systematic review of the evidence. Anesthesiology 108: 1117-1140.
17. The Nordic Medico-Statistical Committee (NOMESCO) Classifcation of Surgical Procedures (NSCP).
18. McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, et al. (2011) Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients. Anesthesiology 114: 318-329.
19. http://www.medicines.org.uk/EMC/medicine/21299/SPC/Bridion+100+mg+ml+solution+for+injection
20. Rahe-Meyer N, Berger C, Wittmann M, Abels E, Reuter DA (2011) Sugammadex provides rapid and predictable recovery in patients undergoing surgery with deep neuromuscular blockade: A multicentre phase III study. Eur J Anaesthesiol 9AP3-9.
21. Sabo D, Jones RK, Berry J, Sloan T, Chen JY, et al. (2011) Residual neuromuscular blockade at extubation: a randomized comparison of sugammadex and neostigmine reversal of rocuronium-induced blockade in patients undergoing abdominal surgery. J Anesthe Clinic Res 2: 140.
22. Duvaldestin P, Kuizenga K, Saldien V, Claudius C, Servin F, et al. (2010) A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevofurane anesthesia. AnesthAnalg 110: 74-82.
23. Groudine SB, Soto R, Lien C, Drover D, Roberts K (2007) A randomized, dose-fnding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. AnesthAnalg 104: 555-562.
24. Snoeck MMJ, Hollmann MW, Buerkle C, Prins ME, Harper NJ (2011) Efficacy and safety of sugammadex reversal of deep rocuronium-induced blockade in patients with severe renal impairment: A case-control study. Eur J Anaesthesiol 9AP2-7.
25. Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, et al. (2006) Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-fnding and safety study. Anesthesiology 104: 667-674.
26. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, et al. (2007) Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety and pharmacokinetics. Anesthesiology 106: 935-943.